Mishra Prashant, Jadhav Ranjit B, Mohapatra Chandan Kumar Ray, Khandekar Jayant, Raut Chaitanya, Ammannaya Ganesh Kumar, Seth Harsh S, Singh Jaskaran, Shah Vaibhav
Department of Cardiovascular Thoracic Surgery, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.
Kardiochir Torakochirurgia Pol. 2016 Dec;13(4):295-299. doi: 10.5114/kitp.2016.64867. Epub 2016 Dec 30.
St. Thomas' cardioplegic solution No. 2 (ST), although most widely used in adult cardiac surgery, needs to be given at short intervals, causing additional myocardial injury.
To determine whether del Nido (DN) cardioplegia, with longer periods of arrest, provides equivalent myocardial protection as compared to ST.
The study population comprised 100 patients who underwent elective coronary artery bypass grafting (CABG) or double valve replacement (DVR) surgery between January 2015 and January 2016. The patients were divided into two groups based on the type of cardioplegia administered during surgery: 1) intermittent ST (ST, = 50) and 2) DN cardioplegia (DN, = 50). We compared the aortic cross clamp (CC) and cardiopulmonary bypass (CPB) times, number of intra-operative DC shocks required, and postoperative changes in left ventricular ejection fraction (LVEF) in the two groups.
The aortic cross clamp and bypass times were shorter with DN (110.15 ±36.84 vs. 133.56 ±35.66 and 158.60 ±39.92 vs. 179.81 ±42.36 min respectively, < 0.05). Fewer cardioplegia doses were required in the DN group vs. the ST group (1.38 ±0.59 vs. 4.15 ±1.26; = 0.001), while a single cardioplegia dose was given to 35 DN patients (70%) vs. 0 ST patients ( < 0.001). Postoperative LVEF was better preserved in the DN group.
The use of DN leads to shorter cross clamp and CPB times, reduces cardioplegia dosage, and provides potentially better myocardial protection in terms of LVEF preservation, with a safety profile comparable to ST cardioplegia.
圣托马斯2号心脏停搏液(ST)虽然在成人心脏手术中使用最为广泛,但需要短时间间隔给药,会造成额外的心肌损伤。
确定与ST相比,停搏时间更长的德尔尼多(DN)心脏停搏液是否能提供同等的心肌保护。
研究对象为2015年1月至2016年1月期间接受择期冠状动脉旁路移植术(CABG)或双瓣膜置换术(DVR)的100例患者。根据手术期间给予的心脏停搏液类型将患者分为两组:1)间歇性ST(ST组,n = 50)和2)DN心脏停搏液(DN组,n = 50)。我们比较了两组的主动脉阻断钳夹(CC)和体外循环(CPB)时间、术中所需直流电除颤次数以及术后左心室射血分数(LVEF)的变化。
DN组的主动脉阻断钳夹和体外循环时间更短(分别为110.15±36.84与133.56±35.66分钟,以及158.60±39.92与179.81±42.36分钟,P<0.05)。与ST组相比,DN组所需的心脏停搏液剂量更少(1.38±0.59与4.15±1.26;P = 0.001),而35例DN患者(70%)给予单次心脏停搏液剂量,ST组为0例患者(P<0.001)。DN组术后LVEF得到更好的保留。
使用DN可缩短阻断钳夹和CPB时间,减少心脏停搏液用量,并在LVEF保留方面提供潜在更好的心肌保护,其安全性与ST心脏停搏液相当。